Director Business Develoment and Operations @ (June 2019 - June 2023)
Vice-Chair - Life Sciences @ (May 2019 - August 2024)
Executive Committee Member @ (October 2018 - July 2024)
Member Administrative Board @ (September 2014 - July 2024)
Chief Business Officer @ (July 2023 - June 2024)
Business Development and CBO @ (September 2021 - July 2023)
Business Development @ (September 2018 - May 2022)
Consultant, Business Development @ (August 2018 - July 2020)
Partner @ Procela Partners (July 2017 - August 2019)
Director Partnering and Licensing @ (August 2016 - December 2017)
Senior Director Business Development @ (September 2015 - July 2017)
MVA Ambassador @ (June 2014 - June 2015)
Advisor and EIR @ North Shore InnoVentures (June 2011 - March 2014)
Consultant @ Biota Holdings Limited (Biota Pharmaceuticals, Inc., acquired by Avirogen) (March 2010 - June 2011)
Co-Founder; Head Chemistry and R and D Operations @ (August 2003 - April 2010)
Founder and Principal @ NEPAssociates (February 2003 - April 2009)
Project Director @ (January 2000 - January 2003)
Associate Director of Chemistry @ RiboGene, Inc. (January 1998 - January 2000)
Senior Scientist @ R. W. Johnson Pharmaceutical Reserarch Institute (October 1989 - February 1998)
Roger Frechette Education
Yale University
NIH Postoctoral Fellowship (Organic Chemistry)
Wesleyan University
Ph.D. (Organic Chemistry)
College of the Holy Cross
BA (Chemistry)
Berlin Senior High School
Roger Frechette Skills
Assay Development
Biochemistry
Biopharmaceuticals
Biotechnology
Business Development
CRO
Chemistry
Clinical Development
Clinical Trials
Commercialization
Cross-functional Team Leadership
Drug Development
Drug Discovery
Entrepreneurship
FDA
Formulation
GLP
GMP
Genomics
Good Laboratory Practice (GLP)
Immunology
Laboratory
Lead Change
Lead Generation
Lead Optimisation
Licensing
Life Sciences
Lifesciences
Medicinal Chemistry
Mergers & Acquisitions
Oncology
Organic Chemistry
Patents
Pharmaceutical Industry
Pharmaceutics
Pharmacology
Product Development
Project Management
R&D
Research and Development (R&D)
Science
Start-ups
Strategic Alliances
Strategic Partnerships
Strategy
Technology Transfer
Validation
Venture Capital
Conceptual Modeling
Scientific Background
Admet
Biology
Engagement
Stocks
Innovator
Transitioning
Clinical Research
Toxicity
Contract Negotiation
Public Speaking
Translation
Residence
R
Marketing
Cross Functional Team Leadership
FIX Protocol
High Throughput
Execution
Reproductive Health
Melbourne
Market
Multiple Therapeutic Areas
Mentoring
Drug Delivery
Software
Bioinformatics
Sales
Cardiovascular
Payments
Financial Services
Contractual Agreements
Denmark
Intellectual Property
Stage
Organizer
Cash
Boston
Operations
Cycles
Networking
Funding
Portugal
Introducing
Biomarker Development
Continuum
Diagnostics
Equities
Bacterial
Licensing Agreements
Signalling
Business Planning
Scotland
Spain
Medical Devices
Flat Patterning
Ndas
Good Laboratory Practice Glp
Multi Disciplinary
Project
Mass
Computational Design
Debate
Presentations
Connecticut
Inflammation
Introductions
Engagements
Temporary Placement
Milestone
Deployed
England
Interdisciplinary Research
Acting
Consideration
Breaking
Oversight
Negotiation
Logic Synthesis
Biomarkers
Poland
Chemical
Contractors
Antibacterial
Symposium
Efficacy
Medicine
Active
Therapists
Development
Agreement
Model Development
Market Opportunity Assessment
Skype
Virtual
Steering
Pharmaceutical Research
European Union
Start Ups
Founding
Nih
Scottish
Financial Advisory
Leadership
Parallel Synthesis
Molecular Diagnostics
Applications
Budgets
Forums
Pathway
Business Strategy
Computational
LinkedIn
Capital
Commercial Real Estate
Commercial Products
Microsoft Excel
North America
Tissue
Conferences
Mergers and Acquisitions
Internet Protocols
CMO
Angels
Research
Council
Internal Audit
Research and Development R&d
Business Systems
Renewal
DoD
Prognosis
Partnerships
Portfolio
Research and Development
Good Laboratory Practice
Roger Frechette Summary
Roger Frechette, based in Boston, MA, US, is currently a Entrepreneur in Residence, US-Israel HealthTech Hub Accelerator at Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA. Roger Frechette brings experience from previous roles at Jeevan Therapeutics, New England PharmAssociates (NEPA) and Akelos Inc. Roger Frechette holds a NIH Postoctoral Fellowship in Organic Chemistry @ Yale University. With a robust skill set that includes Assay Development, Biochemistry, Biopharmaceuticals, Biotechnology, Business Development and more. Roger Frechette has 3 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Roger Frechette?
Find contact details for 700 million professionals.